โ Scribed by P. Armitage; J. B. Block; R. Saracci
No coin nor oath required. For personal study only.
This paper summarizes discussions which took place recently between statisticians and medical practitioners about methodological developments in clinical trials in cancer. Some recent mathematical theories for the analysis of censored survival data enable comparisons to be made between the effects of different treatments without rigid assumptions about the shape of the survival curve, and taking into account various disturbing variables. The use of computers for data processing is increasingly important, and great benefits can be derived from the use of general computer programs. Many clinical studies of new agents are of limited value because of the inadequacy or absence of controls. The value of randomization is well known, but some attention is being given to the possibility that randomization might be dispensed with in certain circumstances. Another possibility is the use of special methods of allocation which tend to place the majority of patients on the better treatment. These various suggestions for new approaches to the design of trials are especially important in view of the large number of possible questions to be investigated by trials and the limited resources available.
๐ SIMILAR VOLUMES
An INFORMATION OFFICE ON CLINICAL THERAPEUTICAL TRIALS in the field of cancer has been established by the Committee on Controlled Therapeutical Trials of the International Union Against Cancer. Those who are planning to start a trial will thus be able to obtain from this Office information on simil